share_log

B of A Securities Reinstates Buy on Acumen Pharmaceuticals, Announces $14 Price Target

B of A Securities Reinstates Buy on Acumen Pharmaceuticals, Announces $14 Price Target

B of A 證券恢復對Acumen Pharmicals的買入,宣佈目標股價爲14美元
Benzinga ·  2023/07/20 06:52

B of A Securities analyst Geoff Meacham reinstates Acumen Pharmaceuticals (NASDAQ:ABOS) with a Buy and announces $14 price target.

B of A Securities分析師傑夫·米查姆以買入恢復Acumen Pharmicals(納斯達克股票代碼:ABOS),並宣佈目標股價爲14美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論